Navigation Links
Ultrafast RT-PCR for COVID-19 by Molecular Biology Systems draws Dutch government support
Date:7/2/2020

Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced a publication detailing the use of its revolutionary NEXTGENPCR endpoint thermocycler to test for SARS-CoV-2 with a one-step reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step RT-PCR protocol for the detection of SARS-CoV-2," has been submitted as a preprint is available here: https://www.medrxiv.org/content/10.1101/2020.06.25.20137398v1

“We immediately started with a COVID-19 diagnostic project, since we already got a NEXTGENPCR thermocycler for sepsis diagnostics. Using this technology, we demonstrated with clinical RNA isolates, the ability to dramatically increase SARS-CoV-2 testing throughput without a loss in sensitivity,” says Prof. Dr. Christian Kaltschmidt, Cell Biology of the University of Bielefeld, the senior author of the publication.

MBS has developed and released two software packages that result in a streamlined workflow from isolated nucleic acid sample to result. First, the machine’s operating system has been updated with two enabling features, onboard reverse transcription and 2-step PCR. These features decrease the number of handling steps, and plate shuttling time which together result in an improved, shorter protocol. The second software package automates the measurement and analysis of endpoint fluorescence, allowing users to automate calls based on predetermined thresholds.

“After accelerating the CDC assay, we received a lot of positive feedback,” says MBS CEO and founder, Gert de Vos. “We added software, tested more WHO-recommended protocols and have collaborated with labs to deliver a demonstration of ultrafast RT-PCR for SARS-CoV-2.”

To support companies responding to COVID-19, the Dutch government has awarded funds to MBS. Rosco Ephraïm, Project Manager Impuls Zeeland, stated, "MBS demonstrated a clear contribution to the advancement of SARS-CoV-2 testing both locally and globally, so the government awarded these funds to ensure this innovative company executes its mission.”

With a single NEXTGENPCR system delivering over 570 test results per hour, MBS is now collaborating with government and private testing laboratories in the USA, Europe, the Middle East and Africa to implement this method.

Find out more at http://www.nextgenpcr.com

About Molecular Biology Systems
Molecular Biology Systems, B.V., founded in 2015, is a molecular biology solutions company based in Netherlands. Their NEXTGENPCR thermocycler uses patented heating and cooling technology to reduce PCR amplification cycles from hours to minutes. These technological advances are intended to support laboratorians across the life sciences market reduce costs and accelerate results.

Read the full story at https://www.prweb.com/releases/ultrafast_rt_pcr_for_covid_19_by_molecular_biology_systems_draws_dutch_government_support/prweb17232921.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Ultrafast heating of water -- This pot boils faster than you can watch it
2. Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018
3. USARAD Including its SecondOpinions.com Division, Launches a Screening Program to Provide Medical Expertise During the Current COVID-19 Pandemic
4. OU Health Sciences Center Partners With Pure MHC on COVID-19 Vaccine Project
5. Ixlayer Launches COVID-19 Clinical Testing Platform to Power Labs, and Health Systems for in Clinic and Remote Testing
6. COVID-19 Stimulus Grants for Biotech Research Companies Offered by InstantGMP
7. SIRION Biotech to Present at April 2020 Virtual Investor Summit: Company to present update on support of its COVID-19 project using its viral vector platforms
8. Supporting COVID-19 Responders: Worcester Polytechnic Institute Expands STEM Program in Africa to Address an Anticipated Shortage of Critical Medical Devices
9. Mount Sinai Researchers Collaborate with GenScript to Develop a COVID-19 Antibody to Treat Sick Patients
10. Ofee.Com, An Online Experience Marketplace Is Launched In The Midst Of Covid-19 Pandemic
11. ILC Dover Reacts to Rising Demand for PPE During the COVID-19 Crisis, Rapidly Launches a New Healthcare Respirator Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, based ... entered into license agreements with Housey Pharma’s HMI subsidiary to gain access to ... have annual Research and Development spending in excess of US $10 billion. , ...
(Date:8/7/2020)... ... 06, 2020 , ... Nine middle school teachers from eight ... a unique professional development program that provides advanced STEM (science, technology, engineering and ... nationwide. , Created in partnership between the National Stem Cell Foundation and The ...
(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, ... contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) ... develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... ... “We are thrilled to deliver this new technology to the industry” said Matt ... the market and we were pleased that the IFT jury recognized that.” reFRESH™ couples ... a natural way to extend the shelf life and improve the safety of perishable ...
(Date:7/18/2020)... ... July 17, 2020 , ... ... firm for the life sciences and food industries, is pleased to announce that ... Clinical Research – Business Development. , Charles is an accomplished and results-driven sales ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... announced today that Massachusetts Institute of Technology (MIT) has expanded the company’s ... allows PathSensors to move into the point-of-care diagnostic market, focusing initially on ...
(Date:7/10/2020)... Mass. (PRWEB) , ... July 09, 2020 , ... ... approaches to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., ... team and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. ...
Breaking Biology Technology: